STA – Liquid Anti-Xa recall in Canada: performance issue
In plain language
This recall involves STA – Liquid Anti-Xa products sold in Canada. It's being recalled because of a performance issue that could lead to incorrect heparin level readings. Healthcare professionals should contact the manufacturer for more information.
What to do
- Contact the manufacturer, Diagnostica Stago Sas, if you require additional information.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
STA - Liquid Anti-Xa 4
Model: 00311US
Lot: All lots.
STA - Liquid Anti-Xa 8
Model: 00322US
Lot: All lots.
STA Satellite
Model: 58104
Lot: All lots.
STA - Fib 2, Sta - Fibrinogen 5
Model: 00674
Lot: All lots.
STA Satellite Max
Model: 59004
Lot: All lots.
Why this matters
Underestimation of heparin levels, leading to overdose risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: All lots.
- 3
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: 00311US, 00322US, 00674, 58104, 59004
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Underestimation of heparin levels, leading to overdose risk
What should consumers do?
Contact the manufacturer, Diagnostica Stago Sas, if you require additional information.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Underestimation of heparin levels, leading to overdose risk
When was this product recalled?
This product was recalled on July 31, 2025.
Is the Diagnostica Stago Sas brand affected by this recall?
Yes, Diagnostica Stago Sas products are affected by this recall. This recall involves STA – Liquid Anti-Xa products sold in Canada. It's being recalled because of a performance issue that could lead to incorrect heparin level readings. Healthcare professionals should contact the manufacturer for more information.